Can the MMR vaccine protect transplant kids? new study seeks answers
NCT ID NCT07195032
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether the measles, mumps, and rubella (MMR) vaccine is safe and works well in children aged 1 to 17 who have had a heart transplant. About 60 children will receive the standard MMR vaccine and be monitored for side effects and immune response. The goal is to see if the vaccine can protect these vulnerable children from serious infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT INFECTION PREVENTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Mercy Hospital
RECRUITINGKansas City, Missouri, 64108, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.